Abstract
Introduction

51
Quinolones are one of the most widely used class of antibiotics in human and veterinary for human consumption. The intake of this food can result to health risks, such as 60 allergy problems, toxicity and potential development of resistant bacterial strains when 61 these antibiotic residues pass to humans through the food chain [3] .
62
In order to regulate the use of these substances, to avoid risks to consumer health, the 
Preparation of standard and working solutions 117
Individual ENR, CIP, DIF and SAR stock solutions were prepared at a concentration of 118 100 mg L -1 in HAcO 0.050 mol L -1 .
119
In order to investigate the generation of TPs at different pH values, buffers between pH 120 1.5 and 8.0 were prepared to make the antibiotic working solutions. pH 1.5 was 
126
An aqueous solution of DEMA 0.010 mol L -1 was used for pH 6.5 and 8.0 buffers, the 127 solution was adjusted with HCl 0.1 mol L -1 and NH 3 1.0 mol L -1 , respectively.
128
Phosphate solution (0.050 mol L -1 ) was adjusted to pH 5.0 with NaOH 0.1 mol L -1 .
(HESI) interface. The LC separation was carried out using a Waters Simmetry C 8 50 x 
256
The identification of the different TPs in the preliminary stability study was performed 257 directly by comparison of mass spectral data from samples and blanks.
258
The confirmation and structure elucidation of the identified metabolites and TPs were 259 carried out by the MS/MS spectrum generated by the product ion scan of each ion. Considering that a degradation lower than 10% negligible, at extreme pH values, the 271 compounds do not show significant degradation after applying three F/T cycles. Table 1 shows a summary of the observed TPs from ENR, CIP, DIF and SAR standard 279 solutions when were subjected to different conditions of pH and after applying three F/T 280 cycles. In Table 1 , mass spectral data and MS/MS spectrum for each compound are shown.
281
Proposed structures for each compound are shown in Figures 2 and 3. 
291
Aromatic core reactions were mainly based on the hydroxylation at the two available 292 positions on the aromatic ring, as well as the defluorination of the molecule.
293
Decarboxylated compound were also observed for ENR and SAR, as well as combinations 294 of piperazine ring and aromatic core based reactions.
295
TPENR-1, TPENR-3, TPENR-5, TPENR-9, TPENR-10, TPENR-13, TPENR-14,
296
TPENR-17, TPENR-18, TPCIP-1, TPCIP-4, TPDIF1, TPDIF-3, TPDIF-7, TPSAR-3 and TPSAR-6 are quinolone structures described in literature as photo-degradation products in 298 environmental samples [6] [7] [8] [9] [10] [11] [12] and microbiological transformation products [13] [14] [15] [16] [17] [18] [19] [20] but, to 299 our knowledge, the rest of the observed compounds have not been described previously.
300
From the intensity showed by LC-MS, the different compounds can be divided in three TPENR-21, TPCIP-6, TPDIF-14, TPSAR-12, which show just the opposite behavior.
315
Therefore, the formation of those TPs could explain the behavior showed by the four 316 studied quinolones and the rest of TPs. Table 2 shows a summary of the identified metabolites obtained from the chicken 326 muscle samples from the medicated animals with ENR. In Table 2 , mass spectral data,
327
MS/MS spectrum and the proposed structure for each metabolite are shown.
328
According to the proposed structure for each metabolite shown in Table 2 , main The two most abundant observed metabolites were M2, formed by the N-desethylation 340 of ENR, leading to ciprofloxacin [14, 15, 18, 20, 21] , and M3, originated by the piperazine 341 ring cleavage (deethylation), leading to desethylene-enrofloxacin [14, 15, 18, 20, 21] .
342
Other metabolites which had a great abundance in the samples were M1, M4 and M10. shows the MS/MS spectra of the main metabolites.
366
The compound with m/z 263.0822 ( Figure 5A ) displayed all typical product ions of with a NH 3 substituent in position 7 as is the case for M1 (Table 2) . (Table 2) . 1259, 448.1092, 420.1149, 394.1356, 376.1251, 366.1404, 350.1456, 348.1300, 332 1317 , 354.1253 , 343.0894, 336.1148 , 325.0787, 317.0738, 308.1198 , 299.0994, 280.1248 TPDIF-2 382.1557 1566 , 364.1460 , 338.1665 , 321.1276 , 308.1559 , 293.1086 , 281.1088 , 267.0930 TPDIF-3 386.1308 1312, 516.1155, 488.1219, 462.1418, 444.1317, 434.1475, 418.1526, 416.1359 516. 1165, 502.0996, 474.1052, 448.1265, 430.1160, 420.1310, 404.1363, 402.1210, 386.1261 (*) TPs from ENR also identified as metabolites in the chicken muscle samples (M1, M2, M3, M6, M8, M9, M11, M12, M13 and M14, respectively) Figure 5 .
